MAY 28, 2020 10:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

In situ immune profiling of heart transplant biopsies improves diagnostic accuracy and rejection risk stratification

Sponsored by: Akoya Biosciences
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Physician, Advanced Heart Failure and Transplant Medicine, University of Pennsylvania
    Biography
      My research focuses on applying computer-assisted analytical methods to multidimensional diagnostic data in order to enhance the understanding of human cardiovascular disease. With clinical training in cardiovascular medicine and scientific training in translational research, my research aims to identify appropriate populations and experimental designs for introducing innovative diagnostic and analytical approaches into clinical care.

      Specific areas of interest include computational morphologic analysis of human heart tissue, in-situ molecular diagnostics, and comprehensive characterizations of the role of inflammation and immune cell populations in diseases of the cardiovascular systems. In recent years, I have participated in research characterizing inflammatory markers and immune cell signatures in diseases of the heart and vasculature. I have served as a co-investigator on a prospective clinical trial investigating a targeted tissue sampling and advanced tissue characterization in patients with new- and recent-onset cardiomyopathy. I have also led multiple projects using machine learning computer-vision technologies to identify quantitative morphologic features which strongly predict important patient outcomes in native and transplanted heart tissue samples. My goal is to integrate automated morpho-molecular analysis pipelines with genomic and transcriptomic data to improve prediction and biological characterization of important patient outcomes.

    Abstract
    DATE:  May 28, 2020
    TIME:   10:00am PT, 1:00pm ET
     
    Cardiac allograft rejection is a serious concern in transplant medicine, conferring an increased risk of acute graft failure and adverse patient outcomes. The guideline-directed histologic grading of biopsy tissues for rejection surveillance has modest diagnostic performance, correlating poorly with the clinical trajectory of concurrent rejection events and offering minimal information about future rejection risk. These limitations expose patients to an immediate potential risk of over- or under-treating for rejection, while also imposing a rigid, protocolized rejection surveillance and immunosuppression weaning strategy that appears outdated in an era of precision medicine.
     
    These findings highlight the limitations of the current guideline-recommended biopsy grading standard, while supporting the diagnostic and prognostic importance of the PD1/PD-L1 checkpoint system and regulatory T-cells in cardiac allografts. We believe that the results of this proof-of-concept work will lead to a rethinking of rejection surveillance protocols for heart transplant patients, and may represent an initial step towards identifying molecular targets for immunotherapeutics in transplant medicine.
     
     
    Learning Objectives:
    • Outline the limitations of conventional histologic rejection grading in heart transplant medicine, and how this affects patient outcomes.
    • Outline the potential of in-situ immune-phenotyping for improving diagnostic accuracy and rejection risk stratification.

     

     


    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    MAR 03, 2020 9:00 AM JST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM JST
    DATE: March 3, 2020 TIME: 9:00am JST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid differentiation of HSPCs at the e...
    FEB 25, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 25, 2020 9:00 AM PST
    Learn about how to generate a small scale CAR-T workflow using ThermoFisher products See detailed characterization tools that can be utilized and applied in a CAR-T workflow...
    DEC 10, 2019 9:00 AM PST
    C.E. CREDITS
    DEC 10, 2019 9:00 AM PST
    DATE: December 10, 2019TIME: 9:00am PST, 12:00pm EST A major limitation in the ex vivo expansion of harvested human hematopoietic stem-progenitor cells (HSPCs) is the rapid dif...
    Loading Comments...
    Show Resources
    Event Countdown
    • 0 Days
    • 0 Hours
    • 0 Minutes
    • 0 Seconds